Cargando…

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study

The prognosis of non-small cell lung cancer (NSCLC) is poor, particularly for patients with metastatic disease. Numerous efforts have been made to improve the prognosis of these patients; however, only a small number of studies have explored the occurrence rate and prognostic value of different patt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zihan, Yang, Qiao, Chen, Xiewan, Zheng, Linpeng, Zhang, Luping, Yu, Yongxin, Chen, Mingjing, You, Qiai, Sun, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507334/ https://www.ncbi.nlm.nih.gov/pubmed/31186781 http://dx.doi.org/10.3892/ol.2019.10225

Ejemplares similares

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis
por: Yang, Qiao, et al.
Publicado: (2019)

The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer
por: You, Qiai, et al.
Publicado: (2022)

Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer
por: Zhao, Xianlan, et al.
Publicado: (2022)

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients
por: Yang, Qiao, et al.
Publicado: (2021)

Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
por: Zheng, LinPeng, et al.
Publicado: (2019)

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC
por: Wang, Jianmin, et al.
Publicado: (2019)

Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor
por: Xu, Zihan, et al.
Publicado: (2019)

Prognostic value of site-specific metastases in lung cancer: A population based study
por: Li, Jing, et al.
Publicado: (2019)

The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer
por: Zhang, Longyao, et al.
Publicado: (2022)

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database
por: Chen, Mingjing, et al.
Publicado: (2021)

Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study
por: Yang, Yingnan, et al.
Publicado: (2021)

Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma: A SEER database analysis
por: Cheng, Rui, et al.
Publicado: (2019)

Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis
por: Oweira, Hani, et al.
Publicado: (2017)

Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
por: Badawy, Ahmed Ashour, et al.
Publicado: (2018)

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study
por: Dong, Fan, et al.
Publicado: (2017)

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
por: Li, Yan, et al.
Publicado: (2016)

Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
por: Deberne, Mélanie, et al.
Publicado: (2014)

Prognostic value of metformin for non-small cell lung cancer patients with diabetes
por: Xu, Tongbai, et al.
Publicado: (2018)

Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
por: Chen, Xiewan, et al.
Publicado: (2016)

Prognostic value of transglutaminase 2 in non-small cell lung cancer patients
por: Chihong, Zhu, et al.
Publicado: (2017)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study
por: Chen, Wei-Kang, et al.
Publicado: (2021)

Prognostic value of TIM-1 expression in human non-small-cell lung cancer
por: Zheng, Xiao, et al.
Publicado: (2019)

A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma
por: Cui, Tianxiang, et al.
Publicado: (2016)

Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study
por: Wang, Shuting, et al.
Publicado: (2022)

Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy
por: Qiao, Simiao, et al.
Publicado: (2023)

Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer
por: Xu, Qinghua, et al.
Publicado: (2015)

Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis
por: Gu, Yinfang, et al.
Publicado: (2020)

Prognostic and predictive value of HURP in non-small cell lung cancer
por: Wang, Qi, et al.
Publicado: (2018)

The landscape of small cell lung cancer metastases: Organ specificity and timing
por: Megyesfalvi, Zsolt, et al.
Publicado: (2021)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation
por: Nardone, Valerio, et al.
Publicado: (2016)

The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations
por: Li, Hongwei, et al.
Publicado: (2020)

Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases
por: Qiao, Rong, et al.
Publicado: (2017)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases
por: Zhao, Zhijian, et al.
Publicado: (2019)

Prognostic value of LIPC in non-small cell lung carcinoma
por: Alifano, Marco, et al.
Publicado: (2013)

Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value
por: Sun, Jian-guo, et al.
Publicado: (2009)

The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China
por: Liu, Yifei, et al.
Publicado: (2018)

A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases
por: Li, Xiaohui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nmer2s5vesi978gqonn800rp0l